SKF-89,145
From Wikipedia, the free encyclopedia
 |
|
|---|---|
| Systematic (IUPAC) name | |
| 4-(6-methyl-5,7-dihydro-4H-thieno[2,3-c]pyridin-4-yl)benzene-1,2-diol | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| ATC code | ? |
| PubChem | CID 10061214 |
| Chemical data | |
| Formula | C14H15NO2S |
| Mol. mass | 261.339 g/mol |
|
|
 (what is this?) (verify) |
SKF-89,145 is a drug which acts as a dopamine agonist selective for the D1 subtype. The N-desmethyl derivative SKF-89,626 is also a selective D1 agonist with similar potency and selectivity to SKF 89,145.[1]
[edit] References
- ^ O'Boyle KM, Waddington JL (December 1987). "New substituted 1-phenyl-3-benzazepine analogues of SK&F 38393 and N-methyl-thienopyridine analogues of dihydroxynomifensine with selective affinity for the D-1 dopamine receptor in human post-mortem brain". Neuropharmacology 26 (12): 1807–10. doi:10.1016/0028-3908(87)90139-0. PMID 3501846.
 |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
